Shares of Grail, Inc. (NASDAQ:GRAL - Get Free Report) shot up 9.2% during trading on Tuesday . The stock traded as high as $18.65 and last traded at $19.02. 79,081 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 661,364 shares. The stock had previously closed at $17.42.
Analyst Ratings Changes
GRAL has been the topic of several research reports. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They set a "peer perform" rating on the stock. Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target on the stock. Finally, Guggenheim assumed coverage on Grail in a research note on Thursday, October 17th. They set a "neutral" rating for the company.
Read Our Latest Research Report on GRAL
Grail Stock Performance
The company's fifty day moving average price is $18.36.
Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The business had revenue of $28.65 million during the quarter. Analysts predict that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.
Insider Activity at Grail
In other news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares of the company's stock, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Hedge Funds Weigh In On Grail
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in GRAL. Douglas Lane & Associates LLC purchased a new position in shares of Grail during the 4th quarter worth approximately $3,034,000. A. D. Beadell Investment Counsel Inc. acquired a new stake in Grail during the 4th quarter valued at $430,000. FNY Investment Advisers LLC purchased a new position in Grail during the fourth quarter worth $26,000. 180 Wealth Advisors LLC acquired a new position in shares of Grail in the fourth quarter worth $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management purchased a new stake in shares of Grail in the fourth quarter valued at $387,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Articles
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
